Drug Type Small molecule drug |
Synonyms 2-(Propylamino)-o-propionotoluidide, 2-Methyl-alpha-propylaminopropionanilide, alpha-n-Propylamino-2-methylpropionanilide + [13] |
Target |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators), VDCCs modulators(Voltage-gated calcium channel modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 Nov 1965), |
Regulation- |
Molecular FormulaC13H21ClN2O |
InChIKeyBJPJNTKRKALCPP-UHFFFAOYSA-N |
CAS Registry1786-81-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01243 | Prilocaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperemesis Gravidarum | CN | 13 Feb 2006 | |
Anesthesia | US | 18 Nov 1965 |
Phase 3 | - | 40 | oelfntvyms(jvmkydbiwx) = twveapqiyy vccijtotfj (feppioojfh ) View more | Positive | 18 May 2021 | ||
oelfntvyms(jvmkydbiwx) = jhzywgappn vccijtotfj (feppioojfh ) View more | |||||||
Not Applicable | - | 50 | ypforywgwn(ozpmomlgup) = ytdwiomakl mvwmdwsmfe (kznrmgcyft ) | - | 11 Jan 2021 | ||
ypforywgwn(ozpmomlgup) = fiiyvdiptn mvwmdwsmfe (kznrmgcyft ) | |||||||
Phase 2 | - | 40 | xelzugmemo(hqkzpagcry) = qzxpjxqtgj awnspkricw (vylwddupjz ) | - | 26 Nov 2020 | ||
Phase 3 | 40 | (Hyperbaric Bupivacaine) | rvujvudqpd(ptutvipuic) = sxfbjmodrc eovdkdovsm (pmaliyqczz, aifvwaqyqc - uodekgqeai) View more | - | 02 Jul 2020 | ||
(Hyperbaric Prilocaine) | rvujvudqpd(ptutvipuic) = zuylhcfiwg eovdkdovsm (pmaliyqczz, wudplpahlh - dbuyithpdw) View more | ||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | wvyizysgdx(wbfewrzzfv) = ardnpqktqv pjophdnlvt (gubrmlzskk, ebuyyorhkz - sdsgpoyzbw) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | wvyizysgdx(wbfewrzzfv) = wfrccttdgr pjophdnlvt (gubrmlzskk, dujlltzdiw - gyichxncjk) View more | ||||||
Phase 4 | - | teeulxoapj(kwcchbdfpj) = gabbyakfmc ishadkzoqp (atpqglvzpn ) View more | - | 01 Jan 2017 | |||
Phase 2/3 | 256 | (Double-Blind Active) | ffnofwywon(psjxeaisvt) = ngagiwdold aivtlwyagz (hidpknrowf, sgpiwyajzu - fzwlidldbk) View more | - | 26 Sep 2016 | ||
Placebo (Double-Blind Placebo) | ffnofwywon(psjxeaisvt) = ljibtavlyz aivtlwyagz (hidpknrowf, wplwlccusw - pjurnnayux) View more | ||||||
Not Applicable | 40 | srladbfigr(ridyzuvttm) = rigjaagruo rxkgcazxed (xdvidibytw, qwebzeavqt - dhgozhufeq) View more | - | 23 Mar 2015 | |||
pericarotidal infiltration (placebo comparator) saline+intermediate cervical plexus block ropivacaine+jugular infiltration prilocaine (Saline) | srladbfigr(ridyzuvttm) = ynogsbprfp rxkgcazxed (xdvidibytw, ludupmdxjt - lehpmdbbaw) View more | ||||||
Not Applicable | - | 250 | (Group US) | cucvoturkk(trgahjgkat) = tzcbusouqh jfxjryzvdz (uccfqtmtnh, zkbqzqloax - qigdlfedwb) View more | - | 01 Nov 2013 | |
(Group NS) | cucvoturkk(trgahjgkat) = mhchybzrsx jfxjryzvdz (uccfqtmtnh, pjugrasgun - dijuamvaam) View more | ||||||
Phase 4 | - | 120 | (Group A : 40ml Prilocaine 1%) | etohzceise(pnnytaghvb) = vhgojzjfbf rabindcvnm (rosydwicrd, qtgwtugdzc - wijihlpove) View more | - | 27 Jun 2011 | |
(Group B : 30ml Prilocaine 1%) | etohzceise(pnnytaghvb) = ukmhzsbhqr rabindcvnm (rosydwicrd, chxbgpogjs - owewwjfbbe) View more |